Rani Therapeutics

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday.  According to S-1 filings, shares were estimated to price between $14 and $16…

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments. The idea for this so-called robotic pill came out of a research project around eight years ago…

How Rani Therapeutics’ robotic pill could change subcutaneous injection treatment